Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Available at: Accessed 3/4/2014
A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, TRAIL Receptor 1 & Receptor 2 Agonist Pipeline Analysis 2020 Along with Research TRAIL Receptor 1 & Receptor 2 Agonist -Pipeline Insight, 2020: The report presents an in-depth assessment of TRAIL Receptor 1 & Receptor 2 Agonist including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies
Idiopathic pulmonary fibrosis (IPF): NAC was studied in the PANTHER-IPF trial, a large multicenter RCT
They can advise you on the proper dosage and ensure that there are no potential interactions with any medications you may already be taking
